ATHEROGENICS INC 4
4 · ATHEROGENICS INC · Filed Feb 23, 2005
Insider Transaction Report
Form 4
ATHEROGENICS INCAGIX
WASSERMAN MARTIN A
Sr VP Discovery Research
Transactions
- Exercise/Conversion
Common stock
2005-02-18$6.04/sh+15,500$93,620→ 15,500 total - Exercise/Conversion
Incentive stock option (right to buy)
2005-02-18$6.05/sh−9,500$57,475→ 30,500 totalExercise: $6.05Exp: 2011-12-13→ Common stock (9,500 underlying) - Exercise/Conversion
Incentive stock option (right to buy)
2005-02-18$6.04/sh−15,500$93,620→ 3,500 totalExercise: $6.04Exp: 2011-04-30→ Common stock (15,500 underlying) - Sale
Common stock
2005-02-18$17.65/sh−15,500$273,575→ 0 total - Exercise/Conversion
Common stock
2005-02-18$6.05/sh+9,500$57,475→ 9,500 total - Sale
Common stock
2005-02-18$17.65/sh−9,500$167,675→ 0 total
Footnotes (2)
- [F1]25% of these options vested on 4/30/02, the first anniversary of the date of grant. Following that date, the remaining options vest at a rate of 2%-3% per month over the next 36 months.
- [F2]25% of these options vested on 12/31/02, the first anniversary of the date of grant. Following that date, the remaining options vest at a rate of 2%-3% per month over the next 36 months.